LUCAT1

Across TCGA pan-cancer cohorts, LUCAT1 RNA is linked to patient survival in 28 of 34 cancer types, making it the most broadly survival-associated LUCAT1 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher LUCAT1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LUCAT1 expression acts as an unfavorable survival marker, although some lineages such as COAD and UCEC show a favorable association.

KIRP, KIRC, and KICH are the cancer types where LUCAT1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Median	All	0.791	0.918	<.001	102	view →
KIRC	DFS	Median	All	0.519	0.722	<.001	94	view →
KICH	DFS	Quartile	All	0.661	0.974	.002	82	view →
UVM	OS	Tertile	II,III,IV	0.717	0.890	.003	47	view →
LUAD	DFS	Quartile	All	0.727	0.870	<.001	46	view →
MESO	OS	Quartile	IV	0.191	0.875	.006	42	view →
LIHC	OS	Median	All	0.448	0.650	.001	40	view →
BLCA	DFS	Tertile	All	0.438	0.688	.005	35	view →
LGG	DFS	Quartile	All	0.732	0.867	.001	25	view →
GBM	OS	Tertile	All	0.325	0.468	.012	20	view →
COAD	OS	Tertile	All	0.940	0.788	.008	18	view →
UCEC	DFS	Median	III,IV	0.651	0.484	.037	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 28 lineages.

LUCAT1–KIRP (DFS)

Open the KIRP breakdown →